The present study is the first to demonstrate the direct impact of PSE and LUT on reducing intestinal permeability in MetS-like mice with insulin resistance, as shown by decreased plasma LBP (an intestinal permeability marker, Figure 2). Here, LBP is linked to metabolic syndrome.